Cargando…
Trends in availability and prices of subsidized ACT over the first year of the AMFm: evidence from remote regions of Tanzania
BACKGROUND: The Affordable Medicines Facility for malaria (AMFm) is a pilot supra-national subsidy program that aims to increase access and affordability of artemisinin combination therapy (ACT) in public sector clinics and private retail shops. It is unclear to what extent the AMFm model will trans...
Autores principales: | Yadav, Prashant, Cohen, Jessica L, Alphs, Sarah, Arkedis, Jean, Larson, Peter S, Massaga, Julius, Sabot, Oliver |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502171/ https://www.ncbi.nlm.nih.gov/pubmed/22929587 http://dx.doi.org/10.1186/1475-2875-11-299 |
Ejemplares similares
-
Diffusion of subsidized ACTs in accredited drug shops in Tanzania: determinants of stocking and characteristics of early and late adopters
por: Larson, Peter S, et al.
Publicado: (2013) -
Do Price Subsidies on Artemisinin Combination Therapy for Malaria Increase Household Use?: Evidence from a Repeated Cross-Sectional Study in Remote Regions of Tanzania
por: Cohen, Jessica L., et al.
Publicado: (2013) -
The Affordable Medicines Facility-malaria (AMFm): are remote areas benefiting from the intervention?
por: Ye, Yazoume, et al.
Publicado: (2015) -
Artemisinin-based combination therapy availability and use in the private sector of five AMFm phase 1 countries
por: Davis, Ben, et al.
Publicado: (2013) -
The association between price, competition, and demand factors on private sector anti-malarial stocking and sales in western Kenya: considerations for the AMFm subsidy
por: O’Meara, Wendy Prudhomme, et al.
Publicado: (2013)